Literature DB >> 17305404

Mechanistic basis for inflammation and tumor promotion in lungs of 2,6-di-tert-butyl-4-methylphenol-treated mice: electrophilic metabolites alkylate and inactivate antioxidant enzymes.

Brent W Meier1, Jose D Gomez, Oleg V Kirichenko, John A Thompson.   

Abstract

An established model for mechanistic analysis of lung carcinogenesis involves administration of 3-methylcholanthrene to mice followed by several weekly injections of the tumor promoter 2,6-di-tert-butyl-4-methylphenol (BHT). BHT is metabolized to quinone methides (QMs) responsible for promoting tumor formation. QMs are strongly electrophilic and readily form adducts with proteins. The goal of the present study was to identify adducted proteins in the lungs of mice injected with BHT and to assess the potential impact of these modifications on tumorigenesis. Cytosolic proteins from treated mouse lungs were separated by two-dimensional electrophoresis, adducts detected by immunoblotting, and proteins identified by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Eight adducts were detected in the lungs of most, or all, of six experimental groups of BALB mice. Of these adducts, several were structural proteins, but others, namely, peroxiredoxin 6 (Prx6), Cu,Zn-superoxide dismutase (SOD1), carbonyl reductase, and selenium-binding protein 1, have direct or indirect antioxidant functions. When the 9000g supernatant fraction of mouse lung was treated with BHT-QM (2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone), substantial lipid peroxidation and increases in hydrogen peroxide and superoxide formation were observed. Studies with human Prx6 and bovine SOD1 demonstrated inhibition of enzyme activity concomitant with adduct formation. LC-MS/MS analysis of digests of adducted Prx6 demonstrated adduction of both Cys 91 and Cys 47; the latter residue is essential for peroxidatic activity. Analysis of QM-treated bovine SOD1 by matrix-assisted laser desorption/ionization time-of-flight MS demonstrated the predominance of a monoadduct at His 78. This study provides evidence that indicates Prx6, SOD1, and possibly other antioxidant enzymes in mouse lung are inhibited by BHT-derived QMs leading to enhanced levels of reactive oxygen species and inflammation and providing a mechanistic basis for the effects of BHT on lung tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17305404      PMCID: PMC2570584          DOI: 10.1021/tx060214f

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  43 in total

1.  Crystallographic structures of bovine copper-zinc superoxide dismutase reveal asymmetry in two subunits: functionally important three and five coordinate copper sites captured in the same crystal.

Authors:  M A Hough; S S Hasnain
Journal:  J Mol Biol       Date:  1999-04-02       Impact factor: 5.469

2.  Extensive investigations on oxidized amino acid residues in H(2)O(2)-treated Cu,Zn-SOd protein with LC-ESI-Q-TOF-MS, MS/MS for the determination of the copper-binding site.

Authors:  T Kurahashi; A Miyazaki; S Suwan; M Isobe
Journal:  J Am Chem Soc       Date:  2001-09-26       Impact factor: 15.419

3.  Responses of tumorigenic and non-tumorigenic mouse lung epithelial cell lines to electrophilic metabolites of the tumor promoter butylated hydroxytoluene.

Authors:  Yude Sun; Lori D Dwyer-Nield; Alvin M Malkinson; Yan Ling Zhang; John A Thompson
Journal:  Chem Biol Interact       Date:  2003-03-06       Impact factor: 5.192

4.  Activation of the antioxidant enzyme 1-CYS peroxiredoxin requires glutathionylation mediated by heterodimerization with pi GST.

Authors:  Y Manevich; S I Feinstein; A B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-02       Impact factor: 11.205

Review 5.  Oxidative stress and cell signalling.

Authors:  G Poli; G Leonarduzzi; F Biasi; E Chiarpotto
Journal:  Curr Med Chem       Date:  2004-05       Impact factor: 4.530

6.  Catalytic and structural role of a metal-free histidine residue in bovine Cu-Zn superoxide dismutase.

Authors:  Akira Toyama; Yohko Takahashi; Hideo Takeuchi
Journal:  Biochemistry       Date:  2004-04-27       Impact factor: 3.162

Review 7.  Antioxidant enzymes and redox regulating thiol proteins in malignancies of human lung.

Authors:  Vuokko L Kinnula; Paavo Pääkkö; Ylermi Soini
Journal:  FEBS Lett       Date:  2004-07-02       Impact factor: 4.124

Review 8.  Structure, mechanism and regulation of peroxiredoxins.

Authors:  Zachary A Wood; Ewald Schröder; J Robin Harris; Leslie B Poole
Journal:  Trends Biochem Sci       Date:  2003-01       Impact factor: 13.807

9.  Reduced selenium-binding protein 1 expression is associated with poor outcome in lung adenocarcinomas.

Authors:  Guoan Chen; Hong Wang; Charles T Miller; Dafydd G Thomas; Tarek G Gharib; David E Misek; Thomas J Giordano; Mark B Orringer; Samir M Hanash; David G Beer
Journal:  J Pathol       Date:  2004-03       Impact factor: 7.996

10.  The Drosophila carbonyl reductase sniffer prevents oxidative stress-induced neurodegeneration.

Authors:  Jose A Botella; Julia K Ulschmid; Christoph Gruenewald; Christoph Moehle; Doris Kretzschmar; Katja Becker; Stephan Schneuwly
Journal:  Curr Biol       Date:  2004-05-04       Impact factor: 10.834

View more
  12 in total

Review 1.  Protein damage by reactive electrophiles: targets and consequences.

Authors:  Daniel C Liebler
Journal:  Chem Res Toxicol       Date:  2007-12-04       Impact factor: 3.739

2.  Comparative methods for analysis of protein covalent modification by electrophilic quinoids formed from xenobiotics.

Authors:  Bolan Yu; Zhihui Qin; Gihani T Wijewickrama; Praneeth Edirisinghe; Judy L Bolton; Gregory R J Thatcher
Journal:  Bioconjug Chem       Date:  2009-04       Impact factor: 4.774

3.  Liver protein targets of hepatotoxic 4-bromophenol metabolites.

Authors:  Yakov M Koen; Heather Hajovsky; Ke Liu; Todd D Williams; Nadezhda A Galeva; Jeffrey L Staudinger; Robert P Hanzlik
Journal:  Chem Res Toxicol       Date:  2012-08-03       Impact factor: 3.739

4.  Alterations in the proteome of the respiratory tract in response to single and multiple exposures to naphthalene.

Authors:  Dietmar Kültz; Johnathon Li; Romina Sacchi; Dexter Morin; Alan Buckpitt; Laura Van Winkle
Journal:  Proteomics       Date:  2015-05-13       Impact factor: 3.984

5.  Identification of protein targets of reactive metabolites of tienilic acid in human hepatocytes.

Authors:  Yakov M Koen; Diganta Sarma; Todd D Williams; Nadezhda A Galeva; R Scott Obach; Robert P Hanzlik
Journal:  Chem Res Toxicol       Date:  2012-04-10       Impact factor: 3.739

6.  Formation of covalently bound protein adducts from the cytotoxicant naphthalene in nasal epithelium: species comparisons.

Authors:  Christina DeStefano-Shields; Dexter Morin; Alan Buckpitt
Journal:  Environ Health Perspect       Date:  2010-05       Impact factor: 9.031

7.  Resveratrol attenuates cisplatin renal cortical cytotoxicity by modifying oxidative stress.

Authors:  Monica A Valentovic; John G Ball; J Mike Brown; Marcus V Terneus; Elizabeth McQuade; Stephanie Van Meter; Hayden M Hedrick; Amy Allison Roy; Tierra Williams
Journal:  Toxicol In Vitro       Date:  2013-11-12       Impact factor: 3.500

8.  Measurement of protein sulfhydryls in response to cellular oxidative stress using gel electrophoresis and multiplexed fluorescent imaging analysis.

Authors:  Page C Spiess; Dexter Morin; William T Jewell; Alan R Buckpitt
Journal:  Chem Res Toxicol       Date:  2008-04-17       Impact factor: 3.739

9.  Febuxostat exerts dose-dependent renoprotection in rats with cisplatin-induced acute renal injury.

Authors:  Alaa N A Fahmi; George S G Shehatou; Abdelhadi M Shebl; Hatem A Salem
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-05-23       Impact factor: 3.000

10.  The impact of surfactant protein-A on ozone-induced changes in the mouse bronchoalveolar lavage proteome.

Authors:  Rizwanul Haque; Todd M Umstead; Willard M Freeman; Joanna Floros; David S Phelps
Journal:  Proteome Sci       Date:  2009-03-26       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.